174 related articles for article (PubMed ID: 37876983)
41. Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2.
Wang Y; Gratzke C; Tamalunas A; Rutz B; Ciotkowska A; Strittmatter F; Herlemann A; Janich S; Waidelich R; Liu C; Stief CG; Hennenberg M
Br J Pharmacol; 2016 Dec; 173(23):3342-3358. PubMed ID: 27638545
[TBL] [Abstract][Full Text] [Related]
42. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
[TBL] [Abstract][Full Text] [Related]
43. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
44. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Rademaker A; Lloyd GL; Gann P
J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
[TBL] [Abstract][Full Text] [Related]
45. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate.
He W; Wang X; Zhan D; Li M; Wang Q; Liu J; Liu D; Fu X; Qian Q; Li Y; Chen P; Zeng G; Wang X; DiSanto ME; Zhang X
Clin Sci (Lond); 2021 Jan; 135(1):167-183. PubMed ID: 33393635
[TBL] [Abstract][Full Text] [Related]
46. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
[TBL] [Abstract][Full Text] [Related]
47. The Circadian Syndrome Predicts Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia Better Than Metabolic Syndrome in Aging Males: A 4-Year Follow-Up Study.
Xiong Y; Zhang F; Wu C; Zhang Y; Huang X; Qin F; Yuan J
Front Med (Lausanne); 2021; 8():715830. PubMed ID: 34621761
[No Abstract] [Full Text] [Related]
48. Signaling Role of Adipocyte Leptin in Prostate Cell Proliferation Induced by Trichomonas vaginalis.
Kim JH; Han IH; Shin SJ; Park SY; Chung HY; Ryu JS
Korean J Parasitol; 2021 Jun; 59(3):235-249. PubMed ID: 34218595
[TBL] [Abstract][Full Text] [Related]
49. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
[TBL] [Abstract][Full Text] [Related]
50. An inhibitory effect of Berberine from herbal Coptis chinensis Franch on rat detrusor contraction in benign prostatic hyperplasia associated with lower urinary tract symptoms.
Miao L; Yun X; Yang X; Jia S; Jiao C; Shao R; Hao J; Chang Y; Fan G; Zhang J; Geng Q; Wichai N; Gao X
J Ethnopharmacol; 2021 Mar; 268():113666. PubMed ID: 33301912
[TBL] [Abstract][Full Text] [Related]
51. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
[TBL] [Abstract][Full Text] [Related]
52. Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates.
Wang X; He W; Chen H; Yang R; Su H; DiSanto ME; Zhang X
J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673008
[TBL] [Abstract][Full Text] [Related]
53. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia.
Kyprianou N; Litvak JP; Borkowski A; Alexander R; Jacobs SC
J Urol; 1998 Jun; 159(6):1810-5. PubMed ID: 9598465
[TBL] [Abstract][Full Text] [Related]
54. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
[TBL] [Abstract][Full Text] [Related]
55. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.
Bauman TM; Vezina CM; Huang W; Marker PC; Peterson RE; Ricke WA
Am J Clin Exp Urol; 2014; 2(4):313-22. PubMed ID: 25606577
[TBL] [Abstract][Full Text] [Related]
56. The effect of LHRH antagonist cetrorelix in crossover conditioned media from epithelial (BPH-1) and stromal (WPMY-1) prostate cells.
Siejka A; Schally AV; Barabutis N
Horm Metab Res; 2014 Jan; 46(1):21-6. PubMed ID: 23839655
[TBL] [Abstract][Full Text] [Related]
57. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
58. alpha-Adrenoceptor antagonists in the treatment of benign prostate hyperplasia.
Thiyagarajan M
Pharmacology; 2002 Jul; 65(3):119-28. PubMed ID: 12037374
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.
Kunit T; Gratzke C; Schreiber A; Strittmatter F; Waidelich R; Rutz B; Loidl W; Andersson KE; Stief CG; Hennenberg M
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F823-32. PubMed ID: 25056351
[TBL] [Abstract][Full Text] [Related]
60. Cluster analysis of men undergoing surgery for BPH/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility.
Schneider AJ; Grimes M; Lyon W; Kemper A; Wang S; Bushman W
PLoS One; 2021; 16(5):e0251721. PubMed ID: 34029333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
